Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Plasma selenium over time and cognitive decline in the elderly.

Akbaraly TN, Hininger-Favier I, Carrière I, Arnaud J, Gourlet V, Roussel AM, Berr C.

Epidemiology. 2007 Jan;18(1):52-8. Erratum in: Epidemiology. 2008 Jan;19(1):168. Akbaraly, N Tasnime [corrected to Akbaraly, Tasnime N].

PMID:
17130689
2.

Cognitive decline is associated with systemic oxidative stress: the EVA study. Etude du Vieillissement Artériel.

Berr C, Balansard B, Arnaud J, Roussel AM, Alpérovitch A.

J Am Geriatr Soc. 2000 Oct;48(10):1285-91.

PMID:
11037017
3.

Cognitive decline is related to education and occupation in a Spanish elderly cohort.

Alvarado BE, Zunzunegui MV, Del Ser T, Béland F.

Aging Clin Exp Res. 2002 Apr;14(2):132-42.

PMID:
12092786
4.

Is antioxidant use protective of cognitive function in the community-dwelling elderly?

Gray SL, Hanlon JT, Landerman LR, Artz M, Schmader KE, Fillenbaum GG.

Am J Geriatr Pharmacother. 2003 Sep;1(1):3-10.

PMID:
15555461
5.

Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging.

Weaver JD, Huang MH, Albert M, Harris T, Rowe JW, Seeman TE.

Neurology. 2002 Aug 13;59(3):371-8.

PMID:
12177370
6.
7.

Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study.

Knopman DS, Mosley TH, Catellier DJ, Coker LH; Atherosclerosis Risk in Communities Study Brain MRI Study.

Alzheimers Dement. 2009 May;5(3):207-14. doi: 10.1016/j.jalz.2009.01.027. Epub 2009 Apr 11.

PMID:
19362884
8.

Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.

Graff-Radford NR, Crook JE, Lucas J, Boeve BF, Knopman DS, Ivnik RJ, Smith GE, Younkin LH, Petersen RC, Younkin SG.

Arch Neurol. 2007 Mar;64(3):354-62. Erratum in: Arch Neurol. 2007 Sep;64(9):1246.

PMID:
17353377
9.

Measuring cognitive function with age: the influence of selection by health and survival.

Euser SM, Schram MT, Hofman A, Westendorp RG, Breteler MM.

Epidemiology. 2008 May;19(3):440-7. doi: 10.1097/EDE.0b013e31816a1d31.

PMID:
18414086
10.

Subjective cognitive complaints and cognitive decline: consequence or predictor? The epidemiology of vascular aging study.

Dufouil C, Fuhrer R, Alpérovitch A.

J Am Geriatr Soc. 2005 Apr;53(4):616-21.

PMID:
15817007
11.

Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study.

Beydoun MA, Kaufman JS, Satia JA, Rosamond W, Folsom AR.

Am J Clin Nutr. 2007 Apr;85(4):1103-11.

12.

Body mass index and cognitive decline in a biracial community population.

Sturman MT, de Leon CF, Bienias JL, Morris MC, Wilson RS, Evans DA.

Neurology. 2008 Jan 29;70(5):360-7. Epub 2007 Sep 19.

PMID:
17881716
13.

Selenium and cognitive impairment: a brief-review based on results from the EVA study.

Berr C, Arnaud J, Akbaraly TN.

Biofactors. 2012 Mar-Apr;38(2):139-44. doi: 10.1002/biof.1003. Epub 2012 Mar 15. Review.

PMID:
22419540
14.

Histamine2 receptor antagonist use and decline in cognitive function among community dwelling elderly.

Hanlon JT, Landerman LR, Artz MB, Gray SL, Fillenbaum GG, Schmader KE.

Pharmacoepidemiol Drug Saf. 2004 Nov;13(11):781-7.

PMID:
15386717
15.

Cardiovascular diseases and decline in cognitive function in an elderly community population: the Edinburgh Artery Study.

Rafnsson SB, Deary IJ, Smith FB, Whiteman MC, Fowkes FG.

Psychosom Med. 2007 Jun;69(5):425-34. Epub 2007 Jun 7.

PMID:
17556639
16.

Increase in epinephrine excretion is associated with cognitive decline in elderly men: MacArthur studies of successful aging.

Karlamangla AS, Singer BH, Greendale GA, Seeman TE.

Psychoneuroendocrinology. 2005 Jun;30(5):453-60.

PMID:
15721057
17.

A cross-sectional and longitudinal study of the relationship between walking speed and cognitive function in community-dwelling elderly people.

Soumaré A, Tavernier B, Alpérovitch A, Tzourio C, Elbaz A.

J Gerontol A Biol Sci Med Sci. 2009 Oct;64(10):1058-65. doi: 10.1093/gerona/glp077. Epub 2009 Jun 26.

PMID:
19561146
18.
19.

Rates of decline distinguish Alzheimer's disease and mild cognitive impairment relative to normal aging: integrating cognition and brain function.

Liddell BJ, Paul RH, Arns M, Gordon N, Kukla M, Rowe D, Cooper N, Moyle J, Williams LM.

J Integr Neurosci. 2007 Mar;6(1):141-74.

PMID:
17472227
20.

Depressive symptoms as a predictor of cognitive decline: MacArthur Studies of Successful Aging.

Chodosh J, Kado DM, Seeman TE, Karlamangla AS.

Am J Geriatr Psychiatry. 2007 May;15(5):406-15.

PMID:
17353297

Supplemental Content

Support Center